| Literature DB >> 34063306 |
Mathew J Gregoski1, Janis Newton2, Kathleen Blaylock2, Sheila A O Smith3, David P Turner4.
Abstract
This pilot study investigated the effectiveness of the healthy empowered active lifestyles (HEAL) program to reduce circulatory levels of advanced glycation end products (AGEs) and assess its relationship to BMI, % body fat, fasting glucose, and A1C. The HEAL program was delivered at a local wellness center using a team-based approach and focused on physical activity and dietary education. A sample of twenty primarily European American (19 white, 1 black) participants (i.e., 10 males, 10 females) aged 26 to 71 (m = 48.75 ± 10.26) completed 12 weeks of the HEAL intervention. Pre to post changes in AGEs, BMI, % body fat, fasting glucose, and A1C were examined as primary outcomes. The findings showed participants had the following average reductions: AGEs 36.04 ± 18.48 ug/mL, BMI 2.0 ± 1.2 kg/m2, % body fat 3.18 ± 1.57%, fasting glucose 5.9 ± 17.21 mg/dL, and A1C 0.68 ± 1.11%. All twenty participants successfully completed the entire twelve weeks of the HEAL intervention. The results of this study show that the HEAL intervention provides beneficial reductions of AGEs, BMI, % body fat, fasting glucose, and A1C. In addition, the high adherence shows promise, and demonstrates the potential for HEAL as a behavioral intervention to improve pre-diabetic and other inflammatory related comorbidities. Further replication of results via additional randomized controlled trials is needed.Entities:
Keywords: advanced glycation end products; food; health; lifestyle; nutrition; physicalactivity
Year: 2021 PMID: 34063306 PMCID: PMC8124783 DOI: 10.3390/ijerph18094863
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
HEAL Educational Session.
| Timeline | Topics and Learning Objectives |
|---|---|
| Week 1 | Pretesting |
| Week 2 | Team Building and Comradery |
| Week 3 | Sponsor presentation |
| Week 4 | Sponsor presentation |
| Week 5 | Sponsor presentation |
| Week 6 | Sponsor presentation |
| Week 7 | Sponsor presentation |
| Week 8 | Sponsor presentation |
| Week 9 | Sponsor presentation |
| Week 10 | Sponsor presentation |
Anthropometric and Biomarker Characteristic.
|
|
|
|
|
|
|
|
| Male (10) | 235.36 ± 21.38 | 33.16 ± 2.87 | 32.26 ± 2.88 | 111.20 ± 26.70 | 5.91 ± 0.88 | 68.51 ± 24.61 |
| Female (10) | 180.99 ± 31.89 | 31.24 ± 4.69 | 41.71 ± 3.64 | 97.60 ± 16.32 | 6.08 ± 2.2 | 76.22 ± 20.33 |
| Combined (20) | 208.18 ± 38.42 | 32.20 ± 3.91 | 36.99 ± 5.81 | 104.40 ± 22.64 | 6.00 ± 1.63 | 72.36 ± 22.32 |
|
|
|
|
|
|
|
|
| Male (10) | 221.21 ± 22.84 | 31.20 ± 3.30 | 28.50 ± 3.61 | 106.60 ± 17.79 | 5.28 ± 0.19 | 40.01 ± 17.15 |
| Female (10) | 169.16 ± 30.44 | 29.15 ± 4.64 | 37.12 ± 4.24 | 90.40 ± 7.21 | 5.36 ± 0.84 | 32.62 ± 7.40 |
| Combined (20) | 195.15 ± 37.40 | 30.18 ± 4.06 | 32.85 ± 5.82 | 98.50 ± 15.61 | 5.32 ± 0.59 | 36.32 ± 13.40 |
|
|
|
|
|
|
|
|
| Male (10) | −14.15 ± 7.23 | −1.96 ± 0.99 | −3.07 ± 1.51 | −4.60 ± 18.99 | −0.63 ± 0.79 | −28.49 ± 19.04 |
| Female (10) | −11.84 ± 8.81 | −2.09 ± 1.45 | −3.28 ± 1.71 | −7.20 ± 16.15 | −0.72 ± 1.42 | −43.59 ± 15.22 |
| Combined (20) | −12.99 ± 7.93 | −2.02 ± 1.21 | −3.18 ± 1.57 | −5.90 ± 17.21 | −0.68 ± 1.12 | −36.04 ± 18.48 |
Correlations of Chronological Age and Anthropometric and Biomarker Change Scores.
| Chronological Age | A1C_Delta | AGEs_Delta | BMI_Delta | %BodyFat_Delta | Weight (lbs)_Delta | ||
|---|---|---|---|---|---|---|---|
| Chronological Age | Pearson Correlation | 1 | −0.383 | 0.183 | 0.127 | 0.037 | −0.003 |
| Sig. (2-tailed) | 0.096 | 0.439 | 0.595 | 0.877 | 0.990 | ||
| N | 20 | 20 | 20 | 20 | 20 | 20 | |
| A1C_Delta | Pearson Correlation | −0.383 | 1 | 0.218 | −0.325 | −0.371 | −0.300 |
| Sig. (2-tailed) | 0.096 | 0.356 | 0.162 | 0.107 | 0.199 | ||
| N | 20 | 20 | 20 | 20 | 20 | 20 | |
| AGEs_Delta | Pearson Correlation | 0.183 | 0.218 | 1 | 0.060 | −0.362 | −0.010 |
| Sig. (2-tailed) | 0.439 | 0.356 | 0.803 | 0.117 | 0.966 | ||
| N | 20 | 20 | 20 | 20 | 20 | 20 | |
| BMI_Delta | Pearson Correlation | 0.127 | −0.325 | 0.060 | 1 | 0.647 ** | 0.967 ** |
| Sig. (2-tailed) | 0.595 | 0.162 | 0.803 | 0.002 | 0.000 | ||
| N | 20 | 20 | 20 | 20 | 20 | 20 | |
| %BodyFat_Delta | Pearson Correlation | 0.037 | 0.371 | −0.362 | 0.647 ** | 1 | 0.589 ** |
| Sig. (2-tailed) | 0.877 | 0.107 | 0.117 | 0.002 | 0.006 | ||
| N | 20 | 20 | 20 | 20 | 20 | 20 | |
| Weight(lbs)_Delta | Pearson Correlation | −0.003 | −0.300 | −0.010 | 0.967 ** | 0.589 ** | 1 |
| Sig. (2-tailed) | 0.990 | 0.199 | 0.966 | 0.000 | 0.006 | ||
| N | 20 | 20 | 20 | 20 | 20 | 20 | |
**. Correlation is significant at the 0.01 level (2-tailed).